Bridgefront Capital’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,925
Closed -$120K 322
2022
Q2
$120K Buy
+15,925
New +$120K 0.13% 260